Pacira | PCRX - Zahlungsmittel Und Äquivalente

Aktienkurs
23.79
Täglich Wechseln
-0.03 -0.13%
Monatlich
4.21%
Jährlich
-3.14%
Q2 Prognose
23.14




Zahlungsmittel Und Äquivalente Veränderung Datum
Assertio Holdings USD 38.5M 8.59M 2025-09
Astellas Pharma JPY 188.37B 8.51B 2025-03
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Cara Therapeutics USD 21.42M 770K 2025-09
Coherus Biosciences USD 88.88M 14.47M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
J&J USD 19.71B 1.48B 2025-12
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xeris Pharmaceuticals USD 111.04M 19.44M 2025-12
Xoma USD 143.9M 7.68M 2024-06
Zoetis USD 2.08B 649M 2025-09